4//SEC Filing
Agopyan Nadia 4
Accession 0001209191-21-010256
CIK 0001094038other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:21 PM ET
Size
5.8 KB
Accession
0001209191-21-010256
Insider Transaction Report
Form 4
Agopyan Nadia
VP, Regulatory Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-10+40,000→ 40,000 totalExercise: $3.29Exp: 2031-02-10→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four year period commencing on March 10, 2021 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001784758
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:21 PM ET
- Size
- 5.8 KB